PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025P00462Stability testing services and DRUG MASTER — Adc Therapeutics America, Inc

Adc Therapeutics America, Inc holds $194K across 2 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Adc Therapeutics America, Inc

Recipient

Dec 29, 2027

PoP end

$194K

Obligated

$194K

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Adc Therapeutics America, Inc — $90

Contract facts

NONE

Contract number75N91025P00462

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAdc Therapeutics America, Inc

CAGE8WNM0

UEIY9MBZX2C5RU5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceNEW PROVIDENCE NJ

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startSep 29, 2025

PoP end (current)Dec 29, 2027

Obligated$194K

Current value$194K

Potential value$194K

STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701 is a federal NONE award for Nih Nci held by Adc Therapeutics America, Inc. Estimated value $194K ($194K obligated). Current period of performance ends Dec 29, 2027. Last award drew 1 bidder. Place of performance: NEW PROVIDENCE NJ.

STABILITY TESTING SERVICES AND DRUG MASTER FILE MAINTENANCE FOR ANTIBODY DRUG CONJUGATE ADCT-701

Recompete timing

Public

● Expiring in 476 days

Current PoP ends Dec 29, 2027 (476 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Adc Therapeutics America, Inc — $194K obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$194K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91025P00462?

75N91025P00462 (Stability testing services and DRUG MASTER) is a Nih Nci award with a potential value of $194K, currently held by Adc Therapeutics America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025P00462?

Nih Nci awarded 75N91025P00462 to Adc Therapeutics America, Inc (potential $194K).

Who is the incumbent on 75N91025P00462?

Adc Therapeutics America, Inc is the incumbent with $194K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 29, 2027.

When does Adc Therapeutics America, Inc’s 75N91025P00462 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91025P00462 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Sep 29, 2025